Connexins and apoptotic transformation

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1661-1672

  Kalvelyte, Audrone ^a   Imbrasaite, Ausra ^a   Bukauskiene, Angele ^b   Verselis, Vytas K ^b   Bukauskas, Feliksas F ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Acridine orange; AO; ChF; Chromatin free cells; Connexin; Cx; EB; EGFP; Enhanced green fluorescent protein; Gap junction; GJ; JP; Junctional plaque; NEC; Necrotic cells; Nonviable apoptotic cells; NVA; V; VA; Viable apoptotic cells; Viable non apoptotic cells

Indexed keywords

ANISOMYCIN; CAMPTOTHECIN; CISPLATIN; COLCHICINE; CONNEXIN 32; CONNEXIN 43; CYCLOHEXIMIDE; ETOPOSIDE; GAP JUNCTION PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PACLITAXEL; STAUROSPORINE; ADENOSINE TRIPHOSPHATE; PHOTOPROTEIN;

APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL COMMUNICATION; CELL CONTACT; CELL LABELING; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL TRANSFORMATION; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; FEMALE; FLUORESCENCE MICROSCOPY; GAP JUNCTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; VOLTAGE CLAMP; ARTICLE; BIOSYNTHESIS; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; TIME;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CELL COMMUNICATION; CLONING, MOLECULAR; CONNEXINS; ELECTROPHYSIOLOGY; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; TIME FACTORS; TRANSFECTION;

EID: 0347549593     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00540-9     Document Type: Conference Paper

References (86)

1. Vaux D.L., Korsmeyer S.J. Cell death in development. Cell. 96:1999;245-254.
2. Blatt N.B., Glick G.D. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg. Med. Chem. 9:2001;1371-1384.
3. Kulms D., Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem. Pharmacol. 64:2002;837-841.
4. Scotto C., Deloulme J.C., Rousseau D., Chambaz E., Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell Biol. 18:1998;4272-4281.
5. Pu Y., Luo K.Q., Chang D.C. A Ca(2+) signal is found upstream of cytochrome c release during apoptosis in HeLa cells. Biochem. Biophys. Res. Commun. 299:2002;762-769.
6. Martin M.C., Dransfield I., Haslett C., Rossi A.G. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276:2001;45041-45050.
7. Paul D.L. Molecular cloning of cDNA for rat liver gap junction protein. J. Cell Biol. 103:1986;123-134.
8. Bennett M.V. Connexins in disease [news]. Nature. 368:1994;18-19.
9. Elfgang C., Eckert R., Lichtenberg-Frate H., Butterweck A., Traub O., Klein R.A., Hulser D.F., Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J. Cell Biol. 129:1995;805-817.
10. Goodenough D.A., Goliger J.A., Paul D.L. Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65:1996;475-502.
11. Willecke K., Eiberger J., Degen J., Eckardt D., Romualdi A., Guldenagel M., Deutsch U., Sohl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383:2002;725-737.
12. Musil L.S., Goodenough D.A. Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell. 74:1993;1065-1077.
13. Lo C.W. Genes, gene knockouts, and mutations in the analysis of gap junctions. Dev. Genet. 24(1/2):1999;1-4.
14. Simon A.M., Goodenough D.A. Diverse functions of vertebrate gap junctions. Trends Cell Biol. 8(12):1998;477-483.
15. White T.W., Sellitto C., Paul D.L., Goodenough D.A. Prenatal lens development in connexin43 and connexin50 double knockout mice. Invest. Ophthalmol. Vis. Sci. 42(12):2001;2916-2923.
16. Willecke K., Temme A., Teubner B., Ott T. Characterization of targeted connexin32-deficient mice: a model for the human Charcot-Marie-Tooth (X-type) inherited disease. Ann. N.Y. Acad. Sci. 883:1999;302-309.
17. Mesnil M., Krutovskikh V., Omori Y., Yamasaki H. Role of blocked gap junctional intercellular communication in non-genotoxic carcinogenesis. Toxicol. Lett. 82/83:1995;701-706. [Review].
18. Yamasaki H., Naus C.C. Role of connexin genes in growth control. Carcinogenesis. 17:1996;1199-1213. [Review].
19. Bergoffen J., Scherer S.S., Wang S., Scott M.O., Bone L.J., Paul D.L., Chen K., Lensch M.W., Chance P.F., Fischbeck K.H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
20. Ionasescu V., Searby C., Ionasescu R. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum. Mol. Genet. 3:1994;355-358.
21. Kelsell D.P., Dunlop J., Stevens H.P., Lench N.J., Liang J.N., Parry G., Mueller R.F., Leigh I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 387(6628):1997;80-83.
22. Richard G., Smith L.E., Bailey R.A., Itin P., Hohl D., Epstein E.H. Jr., DiGiovanna J.J., Compton J.G., Bale S.J. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis [see comments]. Nat. Genet. 20(4):1998;366-369.
23. Shiels A., Mackay D., Ionides A., Berry V., Moore A., Bhattacharya S. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am. J. Hum. Genet. 62(3):1998;526-532.
24. Mackay D., Ionides A., Kibar Z., Rouleau G., Berry V., Moore A., Shiels A., Bhattacharya S. Connexin46 mutations in autosomal dominant congenital cataract. Am. J. Hum. Genet. 64(5):1999;1357-1364.
25. Britz-Cunningham S.H., Shah M.M., Zuppan C.W., Fletcher W.H. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N. Engl. J. Med. 332:1995;1323-1329.
26. Sasson R., Amsterdam A. Stimulation of apoptosis in human granulosa cells from in vitro fertilization patients and its prevention by dexamethasone: involvement of cell contact and bcl-2 expression. J. Clin. Endocrinol. Metab. 87:2002;3441-3451.
27. Lin J.H., Weigel H., Cotrina M.L., Liu S., Bueno E., Hansen A.J., Hansen T.W., Goldman S., Nedergaard M. Gap-junction-mediated propagation and amplification of cell injury. Nat. Neurosci. 1:1998;494-500.
28. Krutovskikh V.A., Piccoli C., Yamasaki H., Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene. 21:2002;1989-1999.
29. Plotkin L.I., Manolagas S.C., Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J. Biol. Chem. 277(10):2002;8648-8657.
30. Trosko J.E., Chang C.C. Modulation of cell-cell communication in the cause and chemoprevention/chemotherapy of cancer. Biofactors. 12(1-4):2000;259-263.
31. Tanaka M., Grossman H.B. Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin. Hum. Gene Ther. 12(18):2001;2225-2236.
32. Huang R.P., Hossain M.Z., Huang R., Gano J., Fan Y., Boynton A.L. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int. J. Cancer. 92(1):2001;130-138.
33. Jordan K., Solan J.L., Dominguez M., Sia M., Hand A., Lampe P.D., Laird D.W. Trafficking, assembly, and function of a connexin43-green fluorescent protein chimera in live mammalian cells. Mol. Biol. Cell. 10(6):1999;2033-2050.
34. Swanton E., Bishop N., Woodman P. J. Biol. Chem. 274:1999;37583-37590.
35. Dickinson J.L., Bates E.J., Ferrante A., Antalis T.M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270:1995;27894-27904.
36. Vaillant A.R., Muller R., Langkopf A., Brown D.L. Characterization of the microtubule-binding domain of microtubule-associated protein 1A and its effects on microtubule dynamics. J. Biol. Chem. 273:1998;13973-13981.
37. Achenbach T.V., Muller R., Slater E.P. Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release. J. Biol. Chem. 275:2000;32089-32097.
38. Smith L., Chen L., Reyland M.E., DeVries T.A., Talanian R.V., Omura S., Smith J.B. Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J. Biol. Chem. 275:2000;40620-40627.
39. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275:2000;39435-39443.
40. Janicke R.U., Ng P., Sprengart M.L., Porter A.G. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:1998;15540-15545.
41. Mercille S., Massie B. Induction of apoptosis in oxygen-deprived cultures of hybridoma cells. Cytotechnology. 15:1994;117-128.
42. Bukauskas F.F. Inducing de novo formation of gap junction channels. Methods Mol. Biol. 154:2001;379-393.
43. Bukauskas F.F., Jordan K., Bukauskiene A., Bennett M.V., Lampe P.D., Laird D.W., Verselis V.K. Clustering of connexin 43-enhanced green fluorescent protein gap junction channels and functional coupling in living cells. Proc. Natl. Acad. Sci. U.S.A. 97(6):2000;2556-2561.
44. Bukauskas F, Bennett MVL, Bukauskiene A, Verselis VK. Functional properties of gap junction channels assembled from connexins fused with green-fluorescent protein. In: Proceedings of the 40th American Society for Cell Biology Annual Meeting, San Francisco, CA; 2000. p. 276a.
45. Ebihara L., Steiner E. Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes. J. Gen. Physiol. 102:1993;59-74.
46. Trexler E.B., Bukauskas F.F., Bennett M.V., Bargiello T.A., Verselis V.K. Rapid and direct effects of pH on connexins revealed by the connexin46 hemichannel preparation. J. Gen. Physiol. 113(5):1999;721-742.
47. Castro C., Gomez-Hernandez J.M., Silander K., Barrio L.C. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. 19(10):1999;3752-3760.
48. Contreras J.E., Sanchez H.A., Eugenin E.A., Speidel D., Theis M., Willecke K., Bukauskas F.F., Bennett M.V., Saez J.C. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. U.S.A. 99(1):2002;495-500.
49. Cotrina M.L., Lin J.H., Alves-Rodrigues A., Liu S., Li J., Azmi-Ghadimi H., Kang J., Naus C.C., Nedergaard M. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. U.S.A. 95(26):1998;15735-15740.
50. Bukauskas F.F., Bukauskiene A., Bennett M.V., Verselis V.K. Gating properties of gap junction channels assembled from connexin43 and connexin43 fused with green fluorescent protein. Biophys. J. 81(1):2001;137-152.
51. Bukauskas F.F., Kempf C., Weingart R. Cytoplasmic bridges and gap junctions in an insect cell line (Aedes albopictus). Exp. Physiol. 77:1992;903-911.
52. Bennett M.V., Verselis V.K. Biophysics of gap junctions. Semin. Cell Biol. 3:1992;29-47.
53. Harris A.L. Emerging issues of connexin channels: biophysics fills the gap. Q. Rev. Biophys. 34:2001;325-427.
54. Eghbali B., Kessler J.A., Reid L.M., Roy C., Spray D.C. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10701-10705.
55. Omori Y., Duflot-Dancer A., Mesnil M., Yamasaki H. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects. Toxicol. Lett. 96/97:1998;105-110.
56. Krutovskikh V., Yamasaki H. Connexin gene mutations in human genetic diseases. Mutat. Res. 462(2/3):2000;197-207.
57. Mesnil M., Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60(15):2000;3989-3999.
58. Andrade-Rozental A.F., Rozental R., Hopperstad M.G., Wu J.K., Vrionis F.D., Spray D.C. Gap junctions: the "kiss of death" and the "kiss of life" Brain Res. Brain Res. Rev. 32(1):2000;308-315.
59. Ando Y., Kuroda M., Honda O., Asaumi J., Okumura Y., Takeda Y., Akaki S., Kanazawa S., Kawasaki S., Hiraki Y. The effect of calcium on Fas-mediated apoptosis and secondary necrosis of Jurkat cells. Int. J. Mol. Med. 7:2001;243-247.
60. Baisch H., Bollmann H., Bornkessel S. Degradation of apoptotic cells and fragments in HL-60 suspension cultures after induction of apoptosis by camptothecin and ethanol. Cell Prolif. 32:1999;303-319.
61. Walisser J.A., Thies R.L. Poly(ADP-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents oncosis and permits caspase activation and apoptosis. Exp. Cell Res. 251:1999;401-413.
62. Lemasters J.J., Qian T., He L., Kim J.S., Elmore S.P., Cascio W.E., Brenner D.A. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid. Redox Signal. 4:2002;769-781.
63. Windoffer R., Beile B., Leibold A., Thomas S., Wilhelm U., Leube R.E. Visualization of gap junction mobility in living cells. Cell Tissue Res. 299(3):2000;347-362.
64. Gaietta G., Deerinck T.J., Adams S.R., Bouwer J., Tour O., Laird D.W., Sosinsky G.E., Tsien R.Y., Ellisman M.H. Multicolor and electron microscopic imaging of connexin trafficking. Science. 296:2002;503-507.
65. Lauf U., Giepmans B.N., Lopez P., Braconnot S., Chen S.C., Falk M.M. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10446-10451.
66. Musil L.S., Le A.C., VanSlyke J.K., Roberts L.M. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J. Biol. Chem. 275(33):2000;25207-25215.
67. Castro C., Gomez-Hernandez J.M., Silander K., Barrio L.C. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. 19(10):1999;3752-3760.
68. + fluxes in intact cells. FASEB J. 15(1):2001;10-12.
69. Unger V.M., Kumar N.M., Gilula N.B., Yeager M. Three-dimensional structure of a recombinant gap junction membrane channel. Science. 283(5405):1999;1176-1180.
70. Hand G.M., Muller D.J., Nicholson B.J., Engel A., Sosinsky G.E. Isolation and characterization of gap junctions from tissue culture cells. J. Mol. Biol. 315(4):2002;587-600.
71. Li H., Liu T.F., Lazrak A., Peracchia C., Goldberg G.S., Lampe P.D., Johnson R.G. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J. Cell Biol. 134(4):1996;1019-1030.
72. Boucher S., Bennett S.A.L. Differential connexin expression, gap junction intercellular coupling, and hemichannel formation in NT2/D1 human neural progenitors and terminally differentiated hNT neurons. J. Neurosci. Res. 72:2003;393-404.
73. Stout C.E., Costantin J.L., Naus C.C., Charles A.C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 277:2002;10482-10488.
74. Verselis V.K., Bukauskas F.F. Connexin-GFPs shed light on regulation of cell-cell communication by gap junctions. Curr. Drug Targets. 3:2002;483-499.
75. Laird D.W. The life cycle of a connexin: gap junction formation, removal, and degradation. J. Bioenerg. Biomembr. 28(4):1996;311-318.
76. Laing J.G., Tadros P.N., Green K., Saffitz J.E., Beyer E.C. Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. Cardiovasc. Res. 38(3):1998;711-718.
77. Hertlein B., Butterweck A., Haubrich S., Willecke K., Traub O. Phosphorylated carboxy terminal serine residues stabilize the mouse gap junction protein connexin45 against degradation. J. Membr. Biol. 162(3):1998;247-257.
78. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
79. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1997;1835-1840.
80. Schrier S.M., Florea B.I., Mulder G.J., Nagelkerke J.F., Ijzerman A.P. Apoptosis induced by extracellular ATP in the mouse neuroblastoma cell line N1E-115: studies on involvement of P2 receptors and adenosine. Biochem. Pharmacol. 63:2002;1119-1126.
81. Lo C.W. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice [comment] [editorial]. Circ. Res. 87(5):2000;346-348.
82. Trosko J.E., Chang C.C. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat. Res. 480/481:2001;219-229.
83. Carruba G., Webber M.M., Quader S.T., Amoroso M., Cocciadiferro L., Saladino F., Trosko J.E., Castagnetta L.A. Regulation of cell-to-cell communication in non-tumorigenic and malignant human prostate epithelial cells. Prostate. 50(2):2002;73-82.
84. White T.W. Unique and redundant connexin contributions to lens development. Science. 295(5553):2002;319-320.
85. Nagy J.I., Li W., Hertzberg E.L., Marotta C.A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res. 717(1/2):1996;173-178.
86. Boerma M., Forsberg L., Van Zeijl L., Morgenstern R., De Faire U., Lemne C., Erlinge D., Thulin T., Hong Y., Cotgreave I.A. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J. Intern. Med. 246(2):1999;211-218.